Improving cancer treatment precision with real-time imaging technology
Real-time Volumetric Imaging for Motion Management and Dose Delivery Verification
This study is looking at new ways to use real-time imaging during radiation therapy for cancer to better track tumor movement caused by breathing, which could help deliver more accurate treatment and improve safety for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11065526 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of stereotactic body radiation therapy (SBRT) by developing real-time volumetric imaging techniques. These techniques aim to track tumor movement during treatment, particularly due to patient respiration, allowing for more precise radiation dose delivery. By utilizing advanced imaging methods, the project seeks to eliminate the need for external markers and improve patient safety by adapting treatment in real-time to any unexpected tumor motion. This approach could lead to better outcomes for patients undergoing radiation therapy for cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing stereotactic body radiation therapy for tumors that may move during treatment, such as those in the abdomen.
Not a fit: Patients with stationary tumors or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the accuracy of radiation therapy, leading to better treatment outcomes and reduced side effects for cancer patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for motion management in radiation therapy, indicating that this approach could be effective.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Yang, Xiaofeng — Emory University
- Study coordinator: Yang, Xiaofeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.